Alnylam Pharmaceuticals (ALNY) Q2 2016 Earnings

2MayConfirmed
Q3 2015
Q4 2015
Q1 2016
Q2 2016
-1.21
-1.05
-0.9
-0.74

Details

Expected EPS
-1.08
Actual EPS
-1.21
Surprise EPS
-0.13
Surprise Percent
+12.04%

Description

Alnylam Pharmaceuticals (ALNY) has reported earnings of -1.21 per share for Q2 2016.

0 Comments

Share your thoughts